Development, evaluation and use of COVID-19 vaccines in older adults: Preliminary principles for the pandemic and beyond.
作者信息
Hilmer Sarah N, Petrovic Mirko, Le Couteur David G, Schwartz Janice B, Thuermann Petra
机构信息
Geriatric Subcommittee of the Clinical Division, IUPHAR (International Union of Basic and Clinical Pharmacology), Kansas, USA.
Kolling Institute, Royal North Shore Hospital and University of Sydney, St Leonards, NSW, Australia.
出版信息
Br J Clin Pharmacol. 2021 Sep;87(9):3459-3461. doi: 10.1111/bcp.14967. Epub 2021 Aug 2.
Abstract
摘要
相似文献
1
Development, evaluation and use of COVID-19 vaccines in older adults: Preliminary principles for the pandemic and beyond.老年人中新冠病毒疫苗的研发、评估与使用：大流行期间及之后的初步原则
Br J Clin Pharmacol. 2021 Sep;87(9):3459-3461. doi: 10.1111/bcp.14967. Epub 2021 Aug 2.
2
What COVID vaccines for young kids could mean for the pandemic.针对幼儿的新冠疫苗对疫情意味着什么。
Nature. 2021 Nov;599(7883):18-19. doi: 10.1038/d41586-021-02947-z.
3
[SARS-CoV-2 vaccines].[严重急性呼吸综合征冠状病毒2型疫苗]
Ugeskr Laeger. 2021 Mar 8;183(10).
4
SARS-CoV-2 vaccine candidates in rapid development.正在快速开发的 SARS-CoV-2 疫苗候选物。
Hum Vaccin Immunother. 2021 Mar 4;17(3):644-653. doi: 10.1080/21645515.2020.1804777. Epub 2020 Oct 29.
5
COVID-19 vaccines & pandemic.新冠病毒疫苗与大流行
Indian J Med Res. 2021;153(5&6):517-521. doi: 10.4103/ijmr.ijmr_1821_21.
6
Vaccines against SARS-CoV-2 variants and future pandemics.针对 SARS-CoV-2 变体和未来大流行的疫苗。
Expert Rev Vaccines. 2022 Oct;21(10):1363-1376. doi: 10.1080/14760584.2022.2110075. Epub 2022 Aug 12.
7
The COVID pandemic must lead to tuberculosis vaccines.新冠疫情必定会催生结核病疫苗。
Nature. 2021 Oct;598(7882):540. doi: 10.1038/d41586-021-02892-x.
8
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.新冠疫情期间评估新冠病毒疫苗的挑战。
CMAJ. 2020 Aug 24;192(34):E982-E985. doi: 10.1503/cmaj.201237. Epub 2020 Jul 9.
9
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.SARS-CoV-2/COVID-19 大流行管理的潜在治疗靶点和疫苗开发：近期进展综述。
Front Immunol. 2021 Jun 30;12:658519. doi: 10.3389/fimmu.2021.658519. eCollection 2021.
10
A review of approved COVID-19 vaccines.新冠病毒疫苗批准情况综述。
Rocz Panstw Zakl Hig. 2021;72(3):245-252. doi: 10.32394/rpzh.2021.0177.
引用本文的文献
1
Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia.关键患者人口统计学特征塑造非危重症低氧 COVID-19 肺炎的固有免疫图谱。
JCI Insight. 2023 Aug 22;8(16):e166110. doi: 10.1172/jci.insight.166110.
2
Science fiction has become reality: Best practice for future viral pandemics.科幻已成为现实：未来病毒性大流行的最佳实践。
Br J Clin Pharmacol. 2021 Sep;87(9):3385-3387. doi: 10.1111/bcp.14997. Epub 2021 Aug 2.
本文引用的文献
1
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.科维希德® COVID-19 疫苗在养老院居民中引发的 B 细胞和 T 细胞免疫应答。
Clin Microbiol Infect. 2021 Nov;27(11):1672-1677. doi: 10.1016/j.cmi.2021.06.013. Epub 2021 Jun 24.
2
What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review.在急性医院护理中，经过验证的衰弱评分与 COVID-19 成年患者的死亡率之间存在什么关系？系统评价。
Age Ageing. 2021 May 5;50(3):608-616. doi: 10.1093/ageing/afab008.
3
Correlates of Vaccine-Induced Protection against SARS-CoV-2.疫苗诱导的针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的保护作用的相关因素。
Vaccines (Basel). 2021 Mar 10;9(3):238. doi: 10.3390/vaccines9030238.
4
Vaccines for older adults.老年人疫苗。
BMJ. 2021 Feb 22;372:n188. doi: 10.1136/bmj.n188.
5
Animal and translational models of SARS-CoV-2 infection and COVID-19.SARS-CoV-2 感染和 COVID-19 的动物和转化模型。
Mucosal Immunol. 2020 Nov;13(6):877-891. doi: 10.1038/s41385-020-00340-z. Epub 2020 Aug 20.
6
A Geroscience Perspective on COVID-19 Mortality.衰老科学视角下的 COVID-19 死亡率。
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):e30-e33. doi: 10.1093/gerona/glaa094.
7
Animal models of frailty: current applications in clinical research.衰弱的动物模型：目前在临床研究中的应用
Clin Interv Aging. 2016 Oct 26;11:1519-1529. doi: 10.2147/CIA.S105714. eCollection 2016.
Zotero 插件